EPIRUS生物制药
EPRS

from December 31, 2014 to December 31, 2015 Issuance of common stock Stock issued in connection with purchase of Bioceros Exercise of stock options Retirement of common stock Stock-based compensation expense and vesting of restricted stock

From December 31,2013 to December 31,2014 Exercise of preferred stock warrant Issuance of preferred stock upon conversion of convertible debt Exchange of preferred stock for common stock in connection with the Merger Issuance of preferred stock Extinguishment of convertible notes Issuance of common stock in connection with the Merger Exercise of stock options Issuance of common stock upon vesting of restricted stock units Stock-based compensation expense and vesting of restricted stock On July 15, 2014, our board of directors unanimously approved a 1-for-10 reverse stock split of our common stock, which we effected on July 16, 2014.

from December 31, 2013 to September 30, 2014 Exercise of preferred stock warrant Issuance of preferred stock upon conversion of convertible debt Exchange of preferred stock for common stock in connection with the Merger Issuance of common stock in connection with the Merger Exercise of stock options Issuance of common stock upon vesting of restricted stock units Stock-based compensation expense and vesting of restricted stock On July 15, 2014, our board of directors unanimously approved a 1-for-10 reverse stock split of our common stock, which we effected on July 16, 2014.

Immediately following the consummation of the Merger and after giving effect to the 2014 Reverse Split, the Company had approximately 12,926,593 shares of Common Stock issued and outstanding.

On July 15, 2014, our board of directors unanimously approved a 1-for-10 reverse stock split of our common stock, which we effected on July 16, 2014.

From December 31,2012 to December 31,2013 Exercise of stock options Vesting of restricted stock units Issuance of common stock, net of issuance costs Severance payment settled in stock Partial shares paid out in connection with 1-for-6 stock split

On September 18, 2013, our board of directors unanimously approved a 1-for-6 reverse stock split of our common stock, which we effected on October 3, 2013.

from December 31, 2011 to December 31, 2012 Exercise of stock options Vesting of restricted stock units Issuance of common stock, net of issuance costs Severance payment settled in stock

from December 31, 2010 to December 31, 2011 Exercise of stock options Vesting of restricted stock units Issuance of common stock, net of issuance costs

From Dec 31 2009 to Dec 31 2010 Exercise of stock options Issuance of restricted stock to employees Cancellation of escrow shares in connection with Neuromed merger